Immunopathology of the Pneumocystis Life Cycle Stages

肺孢子虫生命周期阶段的免疫病理学

基本信息

项目摘要

DESCRIPTION (provided by applicant): Fungal organisms in the genus Pneumocystis, were first clinically noticed because they caused an oftentimes lethal pneumonia (PCP) in humans and other mammals with compromised immune status. Today, the niche of these fungi have expanded to include patients with underlying chronic diseases like COPD, where their presence has been suggested to be a co-morbidity factor. Limited progress has been made in understanding the life cycle, transmission, and natural history of Pneumocystis, due in large part to the absence of a continuous in vitro culture system. The strategies used by these organisms to grow and survive in the context of an intact or immune-debilitated host are largely unknown. The actual agent of infection, the transmissive form, has not been identified, nor has its mode of travel, generally thought to be via an airborne spore. The life cycle of Pneumocystis involves trophic forms (trophs), thought to be the vegetative, asexually dividing life cycle stage; as well as several other developmental stages including the cyst form, which contains 8 ascospores. The cyst is distinct from the trophs in that it contains a thick cell wall comprised mostly of B-1,3 glucan; is larger (5-8um vs 1-4um); and stains with the fungal wall stain, methenamine silver. Cyst formation is thought to result from mating of trophs, but the interplay between the asexual and sexual phases is not clear. During the tenure of the previous Merit Review, we found that the treatment of Pneumocystis infections with echinocandins suppressed the formation of B-1,3-glucan thereby dramatically shifting the mixed cyst and troph populations in immunosuppressed mice and rats to one made almost exclusively of trophic forms. Strikingly, the mortality was markedly reduced in these mice, yet large populations of trophs were present in their lungs. Moreover, echinocandin treated mice were unable to transmit the infection. In the present proposal, we will use the echinocandins as molecular tools to dissect the life cycle in a manner that has never been available to investigators before. It is our central hypothesis that the asexual and sexual cycles act in concert to maintain a balance within the mammalian lung that permits a long and sustainable infection that ensures sustained transmission without demise of the host. We posit that cysts are the agents of transmission and the process of cyst formation requires B-1,3-glucan. However, the presence of cysts via B-1,3 glucan induces a detrimental inflammatory response in the host that increases severity of disease. In the present proposal, we will identify the immune responses evoked by each different population and dissect the life cycle of Pneumocystis using the echinocandins. Towards these goals, we propose the following specific aims: (1) Dissect the Pneumocystis life cycle using the echinocandin, anidulafungin, as a molecular tool by transcriptional analyses and in vivo studies to assess transmission and identify the infectious agent of Pneumocystis infection; (2) Characterize the P. murina cyst and trophic form interactions with alveolar macrophages through a series of binding and phagocytosis assays; and (3) Investigate the role of P. murina cysts in the deleterious pulmonary hyperinflammatory response following immune reconstitution by evaluating cytokine and cellular profiles in the lungs of cyst replete and cyst depleted populations of P. murina. PUBLIC HEALTH RELEVANCE: A significant portion of the VA population is comprised of aging veterans for which chronic diseases conditions such as COPD, HIV and lung cancer result in debilitation of their immune systems and put them at risk for opportunistic infections such as Pneumocystis pneumonia. Greater than 40,000 HIV-infected veteran patients have been entered into the VA registry. HIV-infected persons are 60% more likely to develop COPD than their HIV- negative counterparts. The studies proposed herein will identify the infectious agent of Pneumocystis infection and further define its life cycle and the effects of the different life cycle stages on the host immune system. These studies will provide insights for interdiction of infection and identify more effective therapies.
描述(由申请人提供): 肺孢子虫属的真菌生物首先在临床上被注意到,因为它们在免疫状态受损的人类和其他哺乳动物中引起常常致命的肺炎(PCP)。今天,这些真菌的生态位已经扩大到包括患有慢性阻塞性肺病等潜在慢性疾病的患者,其中它们的存在被认为是一种共病因素。在了解肺孢子虫的生命周期,传播和自然史方面取得了有限的进展,这在很大程度上是由于缺乏连续的体外培养系统。这些生物体在完整或免疫衰弱宿主中生长和生存所使用的策略在很大程度上是未知的。实际的感染媒介(传播形式)尚未确定,其传播方式也尚未确定,通常认为是通过空气传播的孢子。肺孢子虫的生命周期包括营养型(trophs),被认为是营养的无性分裂生命周期阶段;以及其他几个发育阶段,包括含有8个子囊孢子的包囊形式。孢囊与营养体的不同之处在于,它含有主要由B-1,3葡聚糖组成的厚细胞壁;较大(5- 8 μ m vs 1- 4 μ m);并且用真菌壁染色剂乌洛托品银染色。孢囊的形成被认为是营养体交配的结果,但无性和有性阶段之间的相互作用尚不清楚。 在上一次Merit审查期间,我们发现用棘白菌素治疗肺孢子虫感染抑制了B-1,3-葡聚糖的形成,从而使免疫抑制小鼠和大鼠中的混合包囊和营养体种群急剧转变为几乎完全由营养体组成的种群。引人注目的是,这些小鼠的死亡率显著降低,但它们的肺中存在大量的营养体。此外,棘白菌素治疗的小鼠不能传播感染。在本提案中,我们将使用棘白菌素作为分子工具,以研究人员以前从未使用过的方式剖析生命周期。 我们的中心假设是,无性和性周期协同作用,以维持哺乳动物肺部的平衡,从而允许长期和可持续的感染,确保持续传播而不会导致宿主死亡。我们认为包囊是传播媒介,包囊形成过程需要B-1,3-葡聚糖。然而,通过B-1,3葡聚糖形成的囊肿会在宿主中诱导有害的炎症反应,从而增加疾病的严重程度。在目前的建议中,我们将确定每个不同的人口引起的免疫反应,并使用棘白菌素解剖肺孢子虫的生命周期。为此,我们提出了以下具体目标:(1)以棘白菌素和阿尼芬净为分子工具,通过转录分析和体内研究来分析肺孢子虫的生活史,以评估肺孢子虫感染的传播和识别感染因子;(2)通过一系列结合和吞噬试验来表征鼠肺孢子虫包囊和营养型与肺泡巨噬细胞的相互作用;和(3)通过评估囊充满和囊耗尽的鼠肺吸虫种群的肺中的细胞因子和细胞谱,研究鼠肺吸虫囊在免疫重建后有害的肺过度炎症反应中的作用。 公共卫生相关性: VA人口的很大一部分是由老年退伍军人组成的,慢性疾病,如COPD,艾滋病毒和肺癌导致他们的免疫系统衰弱,并使他们面临机会性感染的风险,如肺孢子虫肺炎。超过40,000名感染艾滋病毒的退伍军人患者已进入VA登记处。HIV感染者比HIV阴性者患COPD的可能性高60%。本文提出的研究将确定肺孢子虫感染的病原体,并进一步确定其生命周期和不同生命周期阶段对宿主免疫系统的影响。这些研究将为阻断感染提供见解,并确定更有效的治疗方法。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Melanie T Cushion其他文献

Melanie T Cushion的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Melanie T Cushion', 18)}}的其他基金

BLR&D Research Career Scientist Award Application
BLR
  • 批准号:
    10451505
  • 财政年份:
    2020
  • 资助金额:
    --
  • 项目类别:
BLR&D Research Career Scientist Award Application
BLR
  • 批准号:
    10618296
  • 财政年份:
    2020
  • 资助金额:
    --
  • 项目类别:
The role of sex in the life cycle and transmission of Pneumocystis
性在肺孢子虫生命周期和传播中的作用
  • 批准号:
    10350565
  • 财政年份:
    2019
  • 资助金额:
    --
  • 项目类别:
The role of sex in the life cycle of Pneumocystis
性在肺孢子虫生命周期中的作用
  • 批准号:
    10047702
  • 财政年份:
    2018
  • 资助金额:
    --
  • 项目类别:
The role of sex in the life cycle of Pneumocystis
性在肺孢子虫生命周期中的作用
  • 批准号:
    10421251
  • 财政年份:
    2018
  • 资助金额:
    --
  • 项目类别:
International Workshop on Opportunistic Protists (IWOP-14)
机会性原生生物国际研讨会(IWOP-14)
  • 批准号:
    9398434
  • 财政年份:
    2017
  • 资助金额:
    --
  • 项目类别:
Directed Culturing of Pneumocystis Using Metatranscriptomics
利用宏转录组学定向培养肺孢子虫
  • 批准号:
    8664916
  • 财政年份:
    2013
  • 资助金额:
    --
  • 项目类别:
Directed Culturing of Pneumocystis Using Metatranscriptomics
利用宏转录组学定向培养肺孢子虫
  • 批准号:
    8554433
  • 财政年份:
    2013
  • 资助金额:
    --
  • 项目类别:
Immunopathology of the Pneumocystis Life Cycle Stages
肺孢子虫生命周期阶段的免疫病理学
  • 批准号:
    8397516
  • 财政年份:
    2010
  • 资助金额:
    --
  • 项目类别:
Immunopathology of the Pneumocystis Life Cycle Stages
肺孢子虫生命周期阶段的免疫病理学
  • 批准号:
    7929730
  • 财政年份:
    2010
  • 资助金额:
    --
  • 项目类别:

相似海外基金

Interplay between Aging and Tubulin Posttranslational Modifications
衰老与微管蛋白翻译后修饰之间的相互作用
  • 批准号:
    24K18114
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
The Canadian Brain Health and Cognitive Impairment in Aging Knowledge Mobilization Hub: Sharing Stories of Research
加拿大大脑健康和老龄化认知障碍知识动员中心:分享研究故事
  • 批准号:
    498288
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Operating Grants
EMNANDI: Advanced Characterisation and Aging of Compostable Bioplastics for Automotive Applications
EMNANDI:汽车应用可堆肥生物塑料的高级表征和老化
  • 批准号:
    10089306
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Collaborative R&D
Baycrest Academy for Research and Education Summer Program in Aging (SPA): Strengthening research competencies, cultivating empathy, building interprofessional networks and skills, and fostering innovation among the next generation of healthcare workers t
Baycrest Academy for Research and Education Summer Program in Aging (SPA):加强研究能力,培养同理心,建立跨专业网络和技能,并促进下一代医疗保健工作者的创新
  • 批准号:
    498310
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Operating Grants
関節リウマチ患者のSuccessful Agingに向けたフレイル予防対策の構築
类风湿性关节炎患者成功老龄化的衰弱预防措施的建立
  • 批准号:
    23K20339
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Life course pathways in healthy aging and wellbeing
健康老龄化和福祉的生命历程路径
  • 批准号:
    2740736
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Studentship
I-Corps: Aging in Place with Artificial Intelligence-Powered Augmented Reality
I-Corps:利用人工智能驱动的增强现实实现原地老龄化
  • 批准号:
    2406592
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Standard Grant
NSF PRFB FY 2023: Connecting physiological and cellular aging to individual quality in a long-lived free-living mammal.
NSF PRFB 2023 财年:将生理和细胞衰老与长寿自由生活哺乳动物的个体质量联系起来。
  • 批准号:
    2305890
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Fellowship Award
虚弱高齢者のSuccessful Agingを支える地域課題分析指標と手法の確立
建立区域问题分析指标和方法,支持体弱老年人成功老龄化
  • 批准号:
    23K20355
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
「ケア期間」に着目したbiological aging指標の開発
开发聚焦“护理期”的生物衰老指数
  • 批准号:
    23K24782
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了